RxNews Recap for Wednesday 12-23-09 Print E-mail
By Mary Davila   
Wednesday, 23 December 2009 19:34
Below is a list of the companies that made news in the healthcare sector on Wednesday, December 23, 2009.

Biotech investors interested in seeing more details about these companies and a full list of their related stories can do so by typing the stock ticker symbol into the Stock Quotes box on the right side of the page.

Affymetrix, Inc. (NASDAQ: AFFX) today announced that Kevin M. King, President and Chief Executive Officer, will provide a company overview at the J.P. Morgan Healthcare Conference on January 14 in San Francisco.

Bristol-Myers Squibb Company (NYSE:BMY) today updated its 2009 guidance for GAAP and non-GAAP earnings per share from continuing operations.

Bristol-Myers Squibb Company (NYSE: BMY) and Mead Johnson Nutrition Company (NYSE: MJN) announced today the final results of the offer by Bristol-Myers Squibb to exchange up to 170,000,000 shares of common stock of Mead Johnson for outstanding shares of Bristol-Myers Squibb common stock that were validly tendered and not validly withdrawn.

Tongjitang Chinese Medicines Company (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced that it held its Annual General Meeting of Shareholders (AGM) for the fiscal year ended December 31, 2009 this morning at 11 a.m. (local time) in the Company’s executive office located at the following address: 5th Floor, Block B, Nanshan Medical Device Park, 1019 Nanhai Avenue, Nanshan District, Shenzhen, 518067 Guangdong Province, People’s Republic of China.

Eclipsys Corporation®, (NASDAQ:ECLP), The Outcomes Company®, today announced that the company’s focus on delivering an enterprise portfolio of high-quality health information software solutions is reflected in the findings of the 2009 “Top 20 Best in KLAS Award: Software and Professional Services” report (2009 Top 20 Best in KLAS Awards report).

Forest Laboratories (NYSE:FRX) announced today its agreement to acquire additional rights to NXL 104, which amends the terms of its prior agreement with Novexel covering the combination of NXL 104 with ceftaroline and adds additional rights to the combination of ceftazidime and NXL 104, through a transaction with AstraZeneca executed immediately following AstraZeneca’s announced acquisition of Novexel, S.A.

IMAGIN Molecular Corporation (OTCBB: IMGM) has agreed in a letter of intent to issue 49% of the post capitalization of IMGM in exchange for 84,000,000 Positron Corporation common shares plus 100% of the equity of the Planet Green Bottle, all IMGM shares to be distributed to shareholders or affiliates of Planet Green.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that it has completed the acquisition of Neurogen Corporation (NASDAQ: NRGN), following approval of the transaction by Neurogen stockholders earlier today.

MMR Information Systems, Inc. (OTCBB:MMRF) (the "Company"), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (jointly with the Company, "MMR") provides consumer-controlled Personal Health Records ("PHRs") (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), has appointed Ingrid Safranek as its Chief Financial Officer as of December 17, 2009.

Retractable Technologies, Inc.(AMEX: RVP), a leading maker of safety needle devices, announced today that a Tyler, Texas jury returned a verdict on Friday, December 18th in the litigation of Retractable Technologies, Inc. v. OMI (Occupational & Medical Innovations Limited, an Australian public company,) in favor of Retractable on all claims presented to the jury.

Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it is initiating a Phase 2 clinical study of STA-9090 in patients with advanced gastrointestinal stromal tumors (GIST).

Stem Cell Therapy International, Inc. (OTCBB:SCII) announced that its pre-closing conditions for its merger with Histostem Co. Ltd. ("Histostem") are proceeding on schedule with an expected close of the merger in January 2010.

ThermaFreeze Products Corporation (PINKSHEETS: TZPCD), the maker of a family of environmentally-friendly gel pack and ice replacement ICE SHEET products, announced that its Board of Directors has approved a five-for-one forward split of the Company's common stock, payable upon surrender.

Walgreens (NYSE, NASDAQ: WAG), the nation’s largest drugstore chain and industry leader with more than 17,000 certified or licensed immunizers, is now offering H1N1 vaccinations at all of its pharmacies throughout Indiana.

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus